RTI Biologics, Inc. (RTIX)

[surf1944]

8:08AM RTI Biologics beats by $0.02, beats on revs; guides FY11 EPS in-line, raises FY rev guidance; above consensus (RTIX) 3.76 : Reports Q3 (Sep) earnings of $0.05 per share, $0.02 better than the Capital IQ Consensus Estimate of $0.03; revenues rose 1.2% year/year to $42.3 mln vs the $40.6 mln consensus. Co issues mixed guidance for FY11, sees EPS of $0.12-0.14 vs. $0.13 Capital IQ Consensus Estimate; sees FY11 revs of $166-167 mln vs. $165.99 mln Capital IQ Consensus Estimate and above prior guidance of $164-166 mln.